Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
The feature you requested does not exist. However, we suggest the following feature:

Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CVS Health Corporation- CVS

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2019 | 12:57pm EDT

NEW YORK, April 19, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CVS Health Corporation (NYSE: CVS) from May 21, 2015 through February 20, 2019, inclusive (the "Class Period"). The lawsuit seeks to recover damages for CVS investors under the federal securities laws.

Rosen Law Firm, P.A. Logo

To join the CVS class action, go to https://www.rosenlegal.com/cases-register-1532.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR'S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) CVS's financial condition and expected earnings were deteriorating as a result of rising costs and poor results associated with its acquisition of Omnicare, Inc.; and (2) as a result, CVS's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 26, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to https://www.rosenlegal.com/cases-register-1532.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or cases@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com 
www.rosenlegal.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investor-alert-rosen-law-firm-announces-filing-of-securities-class-action-lawsuit-against-cvs-health-corporation-cvs-300835156.html

SOURCE Rosen Law Firm, P.A.


© PRNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
04/19Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CV..
PR
04/17CVS HEALTH CORPORATION : To Hold First Quarter 2019 Conference Call
PR
04/16CVS HEALTH : fined $535K for filling forged Percocet prescriptions
AQ
04/16Health Care, Once a Leader, Stumbles
DJ
04/15Lagging U.S. healthcare stocks could see short-term boost but clouds linger
RE
04/11CVS HEALTH : PBM Solutions Blunted the Impact of Drug Price Inflation, Helped Re..
PR
04/10CVS HEALTH : Big pharma blamed for skyrocketing US drug prices
AQ
04/10Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CV..
PR
04/09Health Care Down on Regulatory Fears -- Health Care Roundup
DJ
04/09UNITEDHEALTH : Heated debate over high drug costs returns to Capitol Hill
AQ
More news
Financials ($)
Sales 2019 252 B
EBIT 2019 13 730 M
Net income 2019 6 511 M
Debt 2019 62 731 M
Yield 2019 3,75%
P/E ratio 2019 10,58
P/E ratio 2020 9,36
EV / Sales 2019 0,52x
EV / Sales 2020 0,48x
Capitalization 68 335 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 72,0 $
Spread / Average Target 37%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors